The FDA has approved a drug for people in the early stages of Alzheimer’s disease. CBS News’ chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.
Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to “CBS Mornings” on YouTube: https://www.youtube.com/CBSMornings
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow "CBS Mornings" on Instagram: https://bit.ly/3A13OqA
Like "CBS Mornings" on Facebook: https://bit.ly/3tpOx00
Follow "CBS Mornings" on Twitter: https://bit.ly/38QQp8B
Subscribe to our newsletter: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact: [email protected]
